This topic has 0 replies, 1 voice, and was last updated 1 year, 4 months ago by MD forums Moderator. Viewing 0 reply threads Author Posts August 19, 2019 at 11:41 am #13513 MD forums ModeratorParticipant The HOPE-2 trial has been cleared by an independent review board to resume testing CAP-1002 therapy on boys and young men with Duchenne muscular dystrophy. Read more about it here. What do you think of this news? Author Posts Viewing 0 reply threads You must be logged in to reply to this topic. Log In Username: Password: Keep me signed in Log in with Facebook or Log In